Universal Registration Document

Overview

The report describes a year of positive clinical progress for Transgene's cancer immunotherapy portfolio, including encouraging interim results for TG4001 and initial data for other clinical-stage candidates. It also documents the establishment of an ESG Committee under Board oversight and continued voluntary ESG reporting. Environmental disclosures include 2022 Scope 2 emissions, water use and a decision to source 50% of electricity from renewable sources.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 5 April 2023
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services